⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TOVX News
Theriva Biologics, Inc.
Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results
globenewswire.com
TOVX
Theriva Biologics Provides Response to Unusual Market Action
globenewswire.com
TOVX
Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
globenewswire.com
TOVX
Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares
globenewswire.com
TOVX
Theriva™ Biologics anuncia próximas ponencias en congresos médicos
globenewswire.com
TOVX
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
globenewswire.com
TOVX
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
globenewswire.com
TOVX